FGFR1 and soft tissue neoplasm: Other RTKs, such as FGFR1 and AXL in the soft tissue tumors, and FGFR1 and ALK in MB-WNT, showed absolute values in the 90th percentile of all tumors, revealing potential therapeutic susceptibilities.